Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Dec 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different types of laser systems—Thulium Fiber Laser (TFL) and Thulio Pulsed Thulium:YAG (p-Tm:YAG)—to see how effectively they can break up kidney stones during a procedure called ureteroscopy. This treatment is used for patients who have kidney stones that are between 7 to 20 mm in size. The study is currently looking for participants who are between 65 and 74 years old and are suitable candidates for this type of surgery.
To be eligible for the trial, participants should have one or more kidney stones of the appropriate size and should be able to consent to the procedure. It’s important for potential participants to know that certain conditions, like having other stones in the ureter or a history of specific surgeries, may exclude them from the study. If you join this trial, you will help researchers understand which laser system works better for treating kidney stones, potentially improving treatment options for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Solitary renal stone 7 to 20 mm in size or in the case of multiple stones the conglomerate diameter (additive maximal diameter of all stones on axial imaging of computed tomography) of 7-20 mm is required
- • Must be a suitable operative candidate for flexible ureteroscopy per American Urological Association guidelines
- • Must be able to give consent
- • Bilateral ureteroscopy will be permitted but only the first side (per surgeon discretion) will be included in the study
- • Surgeons participating in the study must be urological attending surgeons or fellows with subspecialty training in Endourology
- Exclusion Criteria:
- • Concomitant stones in the ureter
- • Prior ipsilateral upper urinary tract reconstructive procedures or history of ipsilateral ureteral stricture
- • Prior radiotherapy to the abdomen or pelvis
- • Neurogenic bladder or spinal cord injury
- • Pregnancy
- • Untreated UTI
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported